Scientific Excellence and Clinical Innovationat the 2026 Hadassah Hematology Conference – RFHMO
Research Fund of the Hadassah Medical Organization (RFHMO) shared a post on LinkedIn:
“On February 12-13, 2026, the Hematology Division at Hadassah convened its annual Research Conference at the Dan Panorama Hotel in Tel Aviv – two intensive days dedicated to scientific excellence, clinical innovation, and interdisciplinary collaboration.
The conference reflected the division’s deep and sustained engagement in research across the full spectrum of hematology. The majority of presentations were conducted by physicians of the department and under their direct supervision, highlighting a strong culture of inquiry spanning basic, translational, and clinical research.
Scientific sessions addressed cutting-edge studies in multiple myeloma and amyloidosis, acute leukemias, lymphoma and CLL, MDS and MPN, coagulation and plasmapheresis, bone marrow transplantation and CAR-T therapies, as well as supportive and palliative medicine.
Annual updates summarized the latest international advances, reinforcing Hadassah’s position at the forefront of global hematologic research.
Beyond scientific depth, the conference emphasized the essential link between research and high-quality patient care. Active research does not exist in isolation, it directly translates into improved diagnostics, innovative therapies, and better clinical outcomes.
A dedicated session on medical education further underscored the division’s commitment to training the next generation of physician-scientists, strengthening Hadassah’s academic identity as a leader in clinical excellence, research innovation, and medical education.
At RFHMO, we are proud to support the research ecosystem that enables these achievements – fostering collaboration, empowering clinicians, and ensuring that scientific discovery continues to shape the future of hematologic care.
Follow RFHMO to stay connected with the research driving tomorrow’s medicine at Hadassah.”
Stay updated with Hemostasis Today.
-
May 16, 2026, 16:22Tareq Abadl: Low Platelets, But the Marrow Is Fighting Back? – Think about IPF
-
May 16, 2026, 16:20Abdallah Othman: Exploring the Detailed Diagram of the Coronary Arteries
-
May 16, 2026, 16:16The Minute That Saved a Life – Elle’s Battle with a Dismissed Blood Clot – National Blood Clot Alliance
-
May 16, 2026, 16:07Pathophysiology of Impaired Hemostasis in GT – Glanzmann’s Research Foundation
-
May 16, 2026, 16:05Ifeanyichukwu Ifechidere: The Overlooked Diagnosis of VWD in Young Girls With Menorrhagia
-
May 16, 2026, 16:04How We Assess Coagulation in Patients on FXa Inhibitors and What May Come Next – Vasculearn Network
-
May 16, 2026, 16:04Paulus Kirchhof: Atrial Fibrillation Burden and Stroke Risk in Patients With Implanted Devices
-
May 16, 2026, 16:02ASTRO-Kids Global Survey Calls for International Guidance On Postthrombotic Care in Children – JTH
-
May 16, 2026, 15:56Luma Mahairi: Social Determinants of Health Across Hematology Shaping The Outcomes